Intrapartum Glucose Control and Risk of Neonatal Hypoglycemia

Launched by UNIVERSITY OF PITTSBURGH · Oct 14, 2024

Keywords

ClinConnect Summary

This clinical trial is looking at how controlling blood sugar levels during labor affects newborns who may be at risk for low blood sugar, a condition known as neonatal hypoglycemia. The study is comparing a more relaxed approach to managing blood sugar levels in pregnant women with diabetes to the standard care that is usually provided during labor. The goal is to see if this different approach can help reduce the number of babies who experience low blood sugar after birth.

To be eligible for this trial, participants need to be pregnant women who are at least 35 weeks along in their pregnancy and have either pre-existing diabetes (Type 1 or Type 2) or diabetes that developed during pregnancy (gestational diabetes). They should also be planning to deliver their baby vaginally at the University of Pittsburgh Medical Center Magee-Womens Hospital. Participants will be closely monitored during labor to manage their blood sugar levels, and their babies' health will also be closely watched after delivery to check for any signs of low blood sugar. This trial is currently recruiting, so if you meet the criteria and are interested, you may have the opportunity to participate.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Pregnant patients with Pre-gestational (Type 1 or Type 2) or Gestational Diabetes
• • Singleton Gestations
• • Greater than or equal to 35 weeks gestation
• • Planned for vaginal delivery at the University of Pittsburgh Medical Center Magee-Womens Hospital (UPMC MWH)
• Exclusion Criteria:
• • Major fetal anomalies anticipated to require NICU admission
• • Planned Cesarean delivery